Skip to main content
SpringerLink
Log in

Disease Management Update

  • From The World Literature
  • Published:
Disease Management & Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals. The use of tradenames, identified by [‘~’] or the use of a registered (®) or trade mark (™), is for product identification purposes only and does not imply endorsement.

  2. The study was supported in part by an unrestricted grant from Servier Laboratories, Ireland.

  3. Including target- or high-dose ACE inhibitors where appropriate.

  4. Costs were those associated with staff time and hospitalization, and were measured from the perspective of a healthcare provider.

  5. The focus was mainly on the US, the UK, France and Germany.

  6. The guidelines were developed by the Panel on Clinical Practices for the Treatment of HIV Infection.

  7. Costs were those associated with the intervention, primary-care depression visits, outpatient psychiatric healthcare visits, antidepressant prescriptions, and inpatient stays.

  8. The study was fully funded by GlaxoSmithKline, New Zealand.

  9. Costs were those related to the total excess gross costs of HIV/AIDS care, discounted at 3% beginning in 2003.

  10. The study was supported by an unrestricted educational grant from Wyeth-Ayerst Pharmaceuticals, US.

  11. Adjusted for age, race, sex, time on welfare, and other psychiatric and chronic medical conditions.

  12. The program was based on the American Academy of Pediatrics guidelines.

References

  • Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA 2003 Jun 18; 289: 3135–44

    Article  PubMed  Google Scholar 

References

  • The study was supported in part by an unrestricted grant from Servier Laboratories, Ireland.

  • Including target- or high-dose ACE inhibitors where appropriate.

  • Costs were those associated with staff time and hospitalization, and were measured from the perspective of a healthcare provider.

  • Ledwidge M, Barry M, Cahill J, et al. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail 2003 Jun; 5: 381–9

    Article  PubMed  Google Scholar 

References

  • McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003 Jun 26; 348; 2635–45

    Article  PubMed  Google Scholar 

  • Steinberg EP. Improving the quality of care — can we practice what we preach? N Engl J Med 2003 Jun 26; 348; 2681–3

    Article  PubMed  Google Scholar 

Reference

  • Siegel D, Lopez J, Meier J, et al. Academic detailing to improve antihypertensive prescribing patterns. Am J Hypertens 2003 Jun; 16: 508–11

    Article  PubMed  Google Scholar 

References

  • The focus was mainly on the US, the UK, France and Germany.

  • The informed patient is straining relations with doctors, pharma warned. Marketletter 2003 Jun 30; 30: 24

Reference

  • Ahmed A, Allman RM, Kiefe CI, et al. Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care. Am Heart J 2003 Jun; 145: 1086–93

    Article  PubMed  Google Scholar 

References

  • Burwen DR, Galusha DH, Lewis JM, et al. National and state trends in quality of care for acute myocardial infraction between 1994–1995 and 1998–1999: the Medicare Health Care Quality Improvement Program. Arch Intern Med 2003 Jun 23; 163: 1430–9

    Article  PubMed  Google Scholar 

  • Seth P, Gore J. Treatment of acute myocardial infarction. Arch Intern Med 2003 Jun 23; 163: 1392–3

    Article  PubMed  Google Scholar 

References

  • The guidelines were developed by the Panel on Clinical Practices for the Treatment of HIV Infection.

  • National Institute of Allergy and Infectious Diseases. Revised guidelines will ease selection of HIV/AIDS treatments [media release] 2003 Jul 14. Available from URL: http://www.niaid.nih.gov

References

  • Rickles NM, Svarstad BL. Using MEDICAID Claims and Dosing Guidelines to assess the prescribing and outcomes of conventional antipsychotics. J Pharmacy Technol 2003 May-Jun; 19: 146–53

    Google Scholar 

References

  • Costs were those associated with direct and indirect expenses, including nursing, medical and pathology services, and power, water and cleaning.

  • Dunlop L, Umstad M, McGrath G, et al. Cost-effectiveness and patient satisfaction with pregnancy day care for hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol 2003 Jun; 43: 207–12

    Article  PubMed  Google Scholar 

References

  • Costs were those associated with the intervention, primary-care depression visits, outpatient psychiatric healthcare visits, antidepressant prescriptions, and inpatient stays.

  • Liu C-F, Hedrick SC, Chaney EF, et al. Cost-effectiveness of collaborative care for depression in a primary care veteran population. Psychiatric Serv 2003 May; 54: 698–704

    Article  Google Scholar 

References

  • The study was fully funded by GlaxoSmithKline, New Zealand.

  • Holt S, Kljakovic M, Reid J, POMS Steering Committee. Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001. N Z Med J 2003 May 16; 116: 1–8

    Google Scholar 

  • Beasley R, Masoli M. Asthma in New Zealand — time to get control [online]. N Z Med J 2003 May 16; 116. Available from URL: http://www.nzma.org.nz

References

  • Jones T, Garlick W. Should drag companies be allowed to talk directly to patients? BMJ 2003 Jun 14; 326: 1302–3

    Article  PubMed  Google Scholar 

Reference

  • Commonwealth Fund. To contain health care costs, US must reduce error, modernize administration [media release] 2003 Jun 11. Available from URL: http://www.cmwf.org

References

  • Costs were those related to the total excess gross costs of HIV/AIDS care, discounted at 3% beginning in 2003.

  • Holtgrave DR, Pinkerton SD. Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States. J of Acquir Immune Deficiency Syndr 2003 Jun 1; 33: 171–4

    Article  Google Scholar 

References

  • National Institute for Clinical Excellence. Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer. Technology Appraisal Guidance 2003 May; 62: 1-24. Available from URL: http://www.nice.org.uk

  • National Institute for Clinical Excellence. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. Technology Appraisal Guidance 2003 May; 61: 1-25. Available from URL: http://www.nice.org.uk

References

  • The study was supported by an unrestricted educational grant from Wyeth-Ayerst Pharmaceuticals, US.

  • Regal RE, DePestel DD, Van den Bussche HL. The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital. Pharmacotherapy 2003 May; 23: 618–24

    Article  PubMed  CAS  Google Scholar 

Reference

  • Barton DM, Baskar V, Kamalakannan D, et al. An assessment of care of paediatric and adolescent patients with diabetes in a large district general hospital. Diabetic Med 2003 May; 20: 394–8

    Article  PubMed  CAS  Google Scholar 

References

  • Adjusted for age, race, sex, time on welfare, and other psychiatric and chronic medical conditions.

  • Mandell DS, Guevara JP, Rostain AL, et al. Medical expenditures among children with psychiatric disorders in a Medicaid population. Psychiatric Serv 2003 Apr; 54: 465–7

    Article  Google Scholar 

Reference

  • The program was based on the American Academy of Pediatrics guidelines.

  • Purcell K, Fergie J. Effect of an educational program on the treatment of RSV lower-respiratory-tract infection. Am J Health Syst Pharm 2003 Apr 15; 60: 759–67

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Disease Management Update. Dis-Manage-Health-Outcomes 11, 603–610 (2003). https://doi.org/10.2165/00115677-200311090-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200311090-00008

Keywords

Search

Navigation